A single-center, randomized Phase 1 study of trivalent influenza vaccine in Volunteers
Latest Information Update: 12 Jan 2022
At a glance
- Drugs Trivalent influenza vaccine-Zosano Pharma (Primary) ; Trivalent influenza vaccine-Zosano Pharma (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
Most Recent Events
- 12 Jan 2022 New trial record
- 05 Jan 2022 According to a Zosano Pharma media release, data from this study were published in the Journal of Vaccines and Immunology.
- 05 Jan 2022 Results presented in a Zosano Pharma media release.